These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23402445)

  • 21. Expanding Health Technology Assessments to Include Effects on the Environment.
    Marsh K; Ganz ML; Hsu J; Strandberg-Larsen M; Gonzalez RP; Lund N
    Value Health; 2016; 19(2):249-54. PubMed ID: 27021760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health technology assessment and comparative effectiveness research: a pharmaceutical industry perspective.
    Hao Y; Thomas A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):447-54. PubMed ID: 23977973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Universal coverage with rising healthcare costs; health outcomes research value in decision-making in Latin America.
    Augustovski F; García Martí S; Pichon Riviere A; Rubinstein A
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):657-9. PubMed ID: 22098279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inaugural Pharmacogenomics Access and Reimbursement Symposium.
    Rogers SL; Patrinos GP; Mitropoulou C; Formea CM; Jones JS; Brown BG
    Pharmacogenomics; 2021 Jun; 22(9):515-517. PubMed ID: 34032472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to choose health technologies to be assessed by HTA? A review of criteria for priority setting.
    Specchia ML; Favale M; Di Nardo F; Rotundo G; Favaretti C; Ricciardi W; de Waure C;
    Epidemiol Prev; 2015; 39(4 Suppl 1):39-44. PubMed ID: 26499414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indicators of health system coverage and activity in Ireland during the economic crisis 2008-2014 - from 'more with less' to 'less with less'.
    Burke S; Thomas S; Barry S; Keegan C
    Health Policy; 2014 Sep; 117(3):275-8. PubMed ID: 25082466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual choice health insurance policy: a proposal and a cost analysis.
    Cheng J; Ives JC
    J Health Care Finance; 2009; 36(2):60-70. PubMed ID: 20499722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HTA Around the World: Broadening Our Understanding of Cross-Country Differences.
    Torbica A
    Value Health; 2020 Jan; 23(1):1-2. PubMed ID: 31952663
    [No Abstract]   [Full Text] [Related]  

  • 29. DEVELOPMENT OF HEALTH TECHNOLOGY ASSESSMENT IN ROMANIA.
    Scintee SG; Ciutan M
    Int J Technol Assess Health Care; 2017 Jan; 33(3):371-375. PubMed ID: 28436346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Values and evidence colliding: health technology assessment in child health.
    Ungar WJ; Prosser LA; Burnett HF
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):417-9. PubMed ID: 23977967
    [No Abstract]   [Full Text] [Related]  

  • 31. Hard choices: Reflections from the tomb of the unknown patient.
    McCabe C; Round J
    Healthc Manage Forum; 2019 Nov; 32(6):288-292. PubMed ID: 31505957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical technology and inequity in health care: the case of Korea.
    Yang BM
    Health Policy Plan; 1993 Dec; 8(4):385-93. PubMed ID: 10131034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indirect costs in health technology assessment].
    Jakubczyk M; Wrona W; Macioch T; Golicki D; Niewada M; Hermanowski T
    Pol Merkur Lekarski; 2010 Jan; 28(163):42-5. PubMed ID: 20369723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying rapid 'de-facto' HTA in resource-limited settings: experience from Romania.
    Lopert R; Ruiz F; Chalkidou K
    Health Policy; 2013 Oct; 112(3):202-8. PubMed ID: 23953877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INTRODUCTION OF HEALTH TECHNOLOGY ASSESSMENT FOR MEDICINES IN SLOVAKIA.
    Tesar T; Hloska A; Wawruch M; Lehocka L; Snopkova M; Masarykova L
    Int J Technol Assess Health Care; 2017 Jan; 33(3):345-349. PubMed ID: 28434416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Development of the Romanian Scorecard HTA System.
    Radu CP; Chiriac ND; Pravat AM
    Value Health Reg Issues; 2016 Sep; 10():41-47. PubMed ID: 27881276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The change of the health insurance policy and social welfare discourse in 1970s].
    Hwang BJ
    Uisahak; 2011 Dec; 20(2):425-62. PubMed ID: 22343702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personal reflections on the high cost of American medical care: many causes but few politically sustainable solutions.
    Schroeder SA
    Arch Intern Med; 2011 Apr; 171(8):722-7. PubMed ID: 21518938
    [No Abstract]   [Full Text] [Related]  

  • 39. Delivering affordable cancer care in high-income countries.
    Sullivan R; Peppercorn J; Sikora K; Zalcberg J; Meropol NJ; Amir E; Khayat D; Boyle P; Autier P; Tannock IF; Fojo T; Siderov J; Williamson S; Camporesi S; McVie JG; Purushotham AD; Naredi P; Eggermont A; Brennan MF; Steinberg ML; De Ridder M; McCloskey SA; Verellen D; Roberts T; Storme G; Hicks RJ; Ell PJ; Hirsch BR; Carbone DP; Schulman KA; Catchpole P; Taylor D; Geissler J; Brinker NG; Meltzer D; Kerr D; Aapro M
    Lancet Oncol; 2011 Sep; 12(10):933-80. PubMed ID: 21958503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A determination of topics for health technology assessment in Thailand: making decision makers involved.
    Lertpitakpong C; Chaikledkaew U; Thavorncharoensap M; Tantivess S; Praditsitthikorn N; Youngkong S; Yothasamut J; Udomsuk K; Sinthitichai K; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S100-9. PubMed ID: 19253492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.